XML 45 R34.htm IDEA: XBRL DOCUMENT v3.24.3
Stockholders' Equity (Tables)
9 Months Ended
Sep. 30, 2024
Stockholders' Equity Note [Abstract]  
Schedule of Designated Preferred Units As of September 30, 2024, the Company has designated the following preferred stock:
Designated Preferred SharesSeptember 30, 2024
Series A4,200 
Series B2,360 
Series C590 
Series D10,000 
Series E 40,000 
Series E-112,960 
Series F-1 24,900 
Series F-224,900 
Series F-334,860 
Series F-424,900 
Total179,670 
Schedule of Avenue Warrant Valued Using the Black-Scholes Option Pricing Method
The Company values stock options using the Black-Scholes option pricing model and used the following assumptions, on a weighted-average basis, during the reporting periods:
 Nine Months Ended September 30,
 20242023
Expected terms (years)5.65.7
Expected volatility114.0%160.4%
Risk-free interest rate4.20%3.99%
Expected dividends0.00%0.00%
Schedule of Stock Option Activity
The following is a summary of stock option activity for the nine months ended September 30, 2024:
Number of Options Weighted Average
Exercise Price Per Share
Weighted Average Grant Date Fair Value Per ShareWeighted Average
Remaining
Contractual Term
(in years)
Aggregate Intrinsic
Value
(in thousands)
Outstanding at January 1, 20244,183,232$8.17 $7.60 8.3$147 
Granted2,282,0965.17 4.228.9
Exercised(70,088)5.19 3.72 221 
Expired(56,910)8.05 7.73
Cancelled/Forfeited(282,602)5.73 5.29
Outstanding at September 30, 20246,055,728$7.19 $6.47 7.6$15,453 
Exercisable at September 30, 20243,373,334$8.59 $7.78 6.5$5,692 
Unvested at September 30, 20242,682,394 $5.42 $4.83 9.1$9,761 
Schedule of Stock Option Shares Outstanding and Exercisable
The following table summarizes information for stock option shares outstanding and exercisable at September 30, 2024:
Options Outstanding
Range of Exercise PricesOutstanding Number of
Options
Weighted Average
Remaining Option Term
(in years)
$2.83 - $51.50
6,055,2297.6
$51.50+
4991.2
6,055,7287.6
Schedule of Recognized Share-based Compensation Cost
The following is a summary of share-based compensation expense in the statement of operations:
Three Months Ended September 30,Nine Months Ended September 30,
(In thousands)2024202320242023
Selling, general and administrative$1,530 $1,674 $5,502 $3,774 
Research and development411 1,027 1,954 2,095 
Cost of goods sold200 129 699 283 
Total$2,141 $2,830 $8,155 $6,152 
Schedule of Warrant Activity
The following is a summary of common stock warrant activity for the nine months ended September 30, 2024:
 Warrants
Weighted Average Exercise Price
Weighted Average
Remaining Life
(in years)
Outstanding at January 1, 20244,665,201$7.76 1.6
Warrants issued1
1,008,1020.01 
Warrants exercised(1,308,473)0.01 
Outstanding and exercisable at September 30, 20244,364,830$8.30 0.8
1All warrants issued in 2024 have been exercised and therefore have no remaining life.
The following is a summary of preferred stock warrant activity for the nine months ended September 30, 2024:
WarrantsWeighted Average Exercise PriceWeighted Average
Remaining Life
(in years)
Outstanding at January 1, 202424,900 $1,000 2.3
Warrants issued— 
Warrants exercised(250)1,000 
Outstanding and exercisable at September 30, 202424,650$1,000 0.2
Schedule of Information Related to Stock Warrants Outstanding and Exercisable
The following table presents information related to common stock warrants outstanding at September 30, 2024:
Warrants Exercisable
Range of Exercise PricesOutstanding
Number of
Warrants
Weighted Average
Remaining Warrant Term
(in years)
Number of Warrants
$0.01737,4212.8737,421
$6.00
16,6660.216,666
$10.003,610,7430.43,610,743
4,364,8300.84,364,830